|
|
|
|
||
Re: capecod1 facts: sava targeted and then monitored to see if they could improve biomarkers, but didn't include cognitive response into their studies to date, to see if the changed biomarkers 'meant anything'. Sava now has to undertake development of a PH 3 to determine whether or not changing a biomarker has the desired effect. avxl included some cognitive response analysis into their studies, and the indications are, there were 'some'... Pretty much sums up the 'facts'... no?? |
return to message board, top of board |